123.07

0.29% -0.36

After Hours: 123.07

Irhythm Holdings Inc (IRTC)

Overview News Price History Option Chain Financials Discussions Forecast

Irhythm Holdings Inc stock is traded at $123.07, with a volume of 444.47K. It is down -0.29% in the last 24 hours and down -3.19% over the past month. iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Previous Close:

$123.43

Open:

$121.47

24h Volume:

444.47K

Relative Volume:

0.74

Market Cap:

$4.06B

Revenue:

$787.85M

Net Income/Loss:

$-27.78M

P/E Ratio:

-141.85

EPS:

-0.8676

Net Cash Flow:

$18.75M

1W Performance:

+2.35%

1M Performance:

-3.19%

6M Performance:

-3.81%

1Y Performance:

-32.44%

1-Day Range:

$120.56

$123.52

1-Week Range:

$115.77

$125.86

52-Week Range:

$100.85

$212.00

Irhythm Holdings Inc Stock (IRTC) Company Profile

Name

Irhythm Holdings Inc

Sector

Healthcare (1074)

Industry

Medical Devices (141)

Phone

415-632-5700

Address

699 8TH STREET, San Francisco, CA

Employee

2,400

Twitter

@iRhythmTech

Next Earnings Date

2026-10-29

Latest SEC Filings

IRTC's Discussions on Twitter

Compare IRTC vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRTC Irhythm Holdings Inc	123.07	4.22B	787.85M	-27.78M	18.75M	-0.8676
ABT Abbott Laboratories	108.33	197.51B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.17	118.14B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	303.13	125.70B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	47.80	71.55B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.90	51.78B	6.30B	1.07B	1.09B	1.8406

Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform
Sep-23-25	Initiated	Evercore ISI	In-line
Aug-20-25	Initiated	BofA Securities	Buy
May-02-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Dec-03-24	Resumed	Wells Fargo	Equal Weight
Oct-04-24	Initiated	Goldman	Neutral
Jun-20-24	Upgrade	Wolfe Research	Peer Perform → Outperform
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Feb-07-23	Initiated	Wells Fargo	Overweight
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Apr-06-22	Initiated	Wolfe Research	Underperform
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform
Dec-21-21	Resumed	Canaccord Genuity	Buy
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight
Dec-15-21	Upgrade	Citigroup	Neutral → Buy
Jun-02-21	Downgrade	Citigroup	Buy → Neutral
Apr-13-21	Downgrade	BTIG Research	Buy → Neutral
Apr-12-21	Downgrade	JP Morgan	Overweight → Neutral
Feb-26-21	Downgrade	Colliers Securities	Buy → Neutral
Jan-29-21	Reiterated	Needham	Hold
Nov-17-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-11-20	Initiated	Needham	Hold
Sep-02-20	Initiated	Robert W. Baird	Neutral
Aug-07-20	Upgrade	Colliers Securities	Neutral → Buy
Aug-05-20	Upgrade	Oppenheimer	Perform → Outperform
Mar-05-20	Initiated	Citigroup	Buy
Feb-06-20	Initiated	BTIG Research	Buy
Jan-10-20	Initiated	William Blair	Outperform
Jan-08-20	Initiated	SunTrust	Buy
Oct-22-19	Initiated	Oppenheimer	Perform
Feb-20-19	Downgrade	Chardan Capital Markets	Buy → Neutral
Sep-13-18	Reiterated	Canaccord Genuity	Buy
Sep-06-18	Initiated	Chardan Capital Markets	Buy
Aug-02-18	Upgrade	Dougherty & Company	Sell → Neutral
Jul-16-18	Downgrade	Dougherty & Company	Neutral → Sell
Dec-01-17	Initiated	Dougherty & Company	Neutral

View All

Irhythm Holdings Inc Stock (IRTC) Latest News

Sep 04, 2026

Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated? - Yahoo Finance

Sep 04, 2026

Sep 03, 2026

iRhythm CFO Daniel G. Wilson Sells 773 Shares to Cover RSU Tax Withholding - Kalkine Media

Sep 03, 2026

Tax-withholding stock sale by iRhythm (IRTC) CFO - Stock Titan

Sep 03, 2026

Aug 31, 2026